NYSEAMERICAN:NAVB - Navidea Biopharmaceuticals Stock Price, Forecast & News

Navidea Biopharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NAVB."

Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) posted its earnings results on Thursday, November, 7th. The biopharmaceutical company reported ($0.17) earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.17). The biopharmaceutical company earned $0.24 million during the quarter. View Navidea Biopharmaceuticals' Earnings History.

Navidea Biopharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Navidea Biopharmaceuticals.

2 analysts have issued twelve-month price objectives for Navidea Biopharmaceuticals' stock. Their forecasts range from $2.00 to $3.00. On average, they anticipate Navidea Biopharmaceuticals' stock price to reach $2.50 in the next year. This suggests a possible upside of 150.0% from the stock's current price. View Analyst Price Targets for Navidea Biopharmaceuticals.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Navidea Biopharmaceuticals in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Navidea Biopharmaceuticals.

News articles about NAVB stock have been trending somewhat negative recently, InfoTrie reports. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Navidea Biopharmaceuticals earned a media sentiment score of -1.7 on InfoTrie's scale. They also gave media stories about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Navidea Biopharmaceuticals.

Navidea Biopharmaceuticals saw a increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,220,000 shares, an increase of 85.7% from the October 31st total of 656,900 shares. Based on an average daily trading volume, of 546,900 shares, the short-interest ratio is presently 2.2 days. Currently, 10.5% of the company's stock are short sold. View Navidea Biopharmaceuticals' Current Options Chain.

Some companies that are related to Navidea Biopharmaceuticals include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), ResMed (RMD), IDEXX Laboratories (IDXX), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Steris (STE) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Navidea Biopharmaceuticals investors own include NovaBay Pharmaceuticals (NBY), Opko Health (OPK), Rexahn Pharmaceuticals (REXN), Inovio Pharmaceuticals (INO), Novavax (NVAX), AcelRx Pharmaceuticals (ACRX), Agenus (AGEN), Catalyst Pharmaceuticals (CPRX), Synergy Pharmaceuticals (SGYP) and SLS International (SLS).

Shares of NAVB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NAVB stock can currently be purchased for approximately $1.00.

Navidea Biopharmaceuticals has a market capitalization of $18.08 million. Navidea Biopharmaceuticals employs 14 workers across the globe.View Additional Information About Navidea Biopharmaceuticals.

The official website for Navidea Biopharmaceuticals is http://www.navidea.com/.

Navidea Biopharmaceuticals' mailing address is 4995 Bradenton Ave Ste 240, DUBLIN, OH 43017-3552, United States. The biopharmaceutical company can be reached via phone at +1-614-7937500.